Controversy and consensus regarding vitamin D: Recent methodological changes and the risks and benefits of vitamin D supplementation

References

• Meyer HE, Holvik K, Lips P. Should vitamin D supplements be recommended to prevent chronic diseases? BMJ 2015;350:h321
   PubMed Web of Science ®Google Scholar
• Harvey NC, Cooper C. Vitamin D: some perspective please. BMJ 2012;345:e4695
   PubMed Web of Science ®Google Scholar
• Bolland MJ, Grey A, Avenell A, et al. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the women's health initiative limited access dataset and meta-analysis. BMJ 2011;342:d2040
   PubMed Web of Science ®Google Scholar
• Chapuy MC, Arlot ME, Delmas PD, Meunier PJ. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 1994;308:1081–2
   PubMed Web of Science ®Google Scholar
• Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670–6
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009;339:b3692. doi: 10.1136/bmj.b3692
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Int Med 2009;169:551–61
   PubMed Web of Science ®Google Scholar
• Fraser WD, Milan AM. Vitamin D assays: past and present debates, difficulties, and developments. Calcif Tissue Int 2013;92:118–27
   PubMed Web of Science ®Google Scholar
• Carter GD. 25-hydroxyvitamin D: a difficult analyte. Clin Chem 2012;58:486–8
   PubMed Web of Science ®Google Scholar
• Carter GD, Jones JC. Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-d. Ann Clin Biochem 2009;46:79–81
   PubMed Web of Science ®Google Scholar
• Brown TA, Prahl JM, DeLuca HF. Partial amino acid sequence of porcine 1,25-dihydroxyvitamin D3 receptor isolated by immunoaffinity chromatography. Proc Nat Acad Sci USA 1988;85:2454–8
   PubMed Web of Science ®Google Scholar
• Bouillon R, Okamura WH, Norman AW. Structure–function relationships in the vitamin D endocrine system. Endocr Rev 1995;16:200–57
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Komm BS, McDonnell DP, et al. Immunoselection of cdnas to avian intestinal calcium binding protein 28k and a novel calmodulin-like protein: assessment of mRNA regulation by the vitamin D hormone. Biochemistry 1987;26:8332–8
   PubMed Web of Science ®Google Scholar
• Anderson PH, Lam NN, Turner AG, et al. The pleiotropic effects of vitamin D in bone. J Steroid Biochem Mol Biol 2013;136:190–4
   PubMed Web of Science ®Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911–30
   PubMed Web of Science ®Google Scholar
• Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003;326:469
   PubMed Web of Science ®Google Scholar
• Avenell A, Gillespie WJ, Gillespie LD, O'Connell D. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 2009;2:CD000227. doi: 10.1002/14651858.CD000227.pub3
   Google Scholar
• Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 2014;348:g2035
   PubMed Web of Science ®Google Scholar
• Bolland MJ, Grey A, Gamble GD, Reid IR. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2014;2:307–20
   PubMed Web of Science ®Google Scholar
• Tang BM, Eslick GD, Nowson C, et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007;370:657–66
   PubMed Web of Science ®Google Scholar
• Geddes JA, Inderjeeth CA. Evidence for the treatment of osteoporosis with vitamin D in residential care and in the community dwelling elderly. Biomed Res Int 2013;2013:463589
   PubMed Web of Science ®Google Scholar
• Smith H, Anderson F, Raphael H, et al. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women–a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) 2007;46:1852–7
   PubMed Web of Science ®Google Scholar
• Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010;303:1815–22
   PubMed Web of Science ®Google Scholar
• Prince RL, Austin N, Devine A, et al. Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch Int Med 2008;168:103–8
   PubMed Web of Science ®Google Scholar
• Sambrook PN, Cameron ID, Chen JS, et al. Does increased sunlight exposure work as a strategy to improve vitamin D status in the elderly: a cluster randomised controlled trial. Osteoporos Int 2012;23:615–24
   PubMed Web of Science ®Google Scholar
• Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 2011;65:1005–15
   PubMed Web of Science ®Google Scholar
• Souberbielle JC, Body JJ, Lappe JM, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev 2010;9:709–15
   PubMed Web of Science ®Google Scholar
• Gandini S, Boniol M, Haukka J, et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2011;128:1414–24
   PubMed Web of Science ®Google Scholar
• Seida JC, Mitri J, Colmers IN, et al. Clinical review: effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2014;99:3551–60
   PubMed Web of Science ®Google Scholar
• Lappe JM, Travers-Gustafson D, Davies KM, et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007;85:1586–91
   PubMed Web of Science ®Google Scholar
• Beveridge LA, Witham MD. Vitamin D and the cardiovascular system. Osteoporos Int 2013;24:2167–80
   PubMed Web of Science ®Google Scholar
• Kestenbaum B, Katz R, de Boer I, et al. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol 2011;58:1433–41
   PubMed Web of Science ®Google Scholar
• Tomaschitz A, Pilz S, Ritz E, et al. Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: the ludwigshafen risk and cardiovascular health (luric) study. Clin Chim Acta 2010;411:1354–60
   PubMed Web of Science ®Google Scholar
• Watson KE, Abrolat ML, Malone LL, et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997;96:1755–60
   PubMed Web of Science ®Google Scholar
• Grundmann M, Haidar M, Placzko S, et al. Vitamin D improves the angiogenic properties of endothelial progenitor cells. Am J Physiol Cell Physiol 2012;303:C954–62
   PubMed Web of Science ®Google Scholar
• Simpson RU, Hershey SH, Nibbelink KA. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol 2007;103:521–4
   PubMed Web of Science ®Google Scholar
• Vaidya A, Pojoga L, Underwood PC, et al. The association of plasma resisting with dietary sodium manipulation, the renin-angiotensin-aldosterone system, and 25-hydroxyvitamin D(3) in human hypertension. Clin Endocrinol 2011;74:294–9
   PubMed Web of Science ®Google Scholar
• Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 2010;55:1283–8
   PubMed Web of Science ®Google Scholar
• Lehto S, Niskanen L, Suhonen M, et al. Medial artery calcification: a neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996;16:978–83
   PubMed Web of Science ®Google Scholar
• Saleh FN, Schirmer H, Sundsfjord J, Jorde R. Parathyroid hormone and left ventricular hypertrophy. Eur Heart J 2003;24:2054–60
   PubMed Web of Science ®Google Scholar
• Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503–11
   PubMed Web of Science ®Google Scholar
• Durup D, Jorgensen HL, Christensen J, et al. A reverse j-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the COPD study. J Clin Endocrinol Metab 2012;97:2644–52
   PubMed Web of Science ®Google Scholar
• de Boer IH, Levin G, Robinson-Cohen C, et al. Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study. Ann Int Med 2012;156:627–34
   PubMed Web of Science ®Google Scholar
• Hirani V, Cumming RG, Naganathan V, et al. Associations between serum 25-hydroxyvitamin D concentrations and multiple health conditions, physical performance measures, disability, and all-cause mortality: the concord health and ageing in men project. J Am Geriatr Soc 2014;62:417–25
   PubMed Web of Science ®Google Scholar
• Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med 2010;88:441–50
   PubMed Web of Science ®Google Scholar
• Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311:1770–3
   PubMed Web of Science ®Google Scholar
• Agmon-Levin N, Theodor E, Segal R, Shoenfeld Y. Vitamin D in systemic and organ-specific autoimmune diseases. Clin Rev Allerg Immunol 2013;45:256–66
   PubMed Web of Science ®Google Scholar
• Yin K, Agrawal DK. Vitamin D and inflammatory diseases. J Inflamm Res 2014;7:69–87
   PubMedGoogle Scholar
• Schleithoff SS, Zittermann A, Tenderich G, et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006;83:754–9
   PubMed Web of Science ®Google Scholar
• Amital H, Szekanecz Z, Szucs G, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 2010;69:1155–7
   PubMed Web of Science ®Google Scholar
• Boissier MC, Semerano L, Challal S, et al. Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction. J Autoimmun 2012;39:222–8
   PubMed Web of Science ®Google Scholar
• Welsh P, Peters MJL, Sattar N. Is vitamin D in rheumatoid arthritis a magic bullet or a mirage? The need to improve the evidence base prior to calls for supplementation. Arthritis Rheum 2011;63:1763–9
   PubMed Web of Science ®Google Scholar
• Zold E, Szodoray P, Nakken B, et al. Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease. Autoimmun Rev 2011;10:155–62
   PubMed Web of Science ®Google Scholar
• Kroger H, Penttila IM, Alhava EM. Low serum vitamin D metabolites in women with rheumatoid arthritis. Scand J Rheumatol 1993;22:172–7
   PubMed Web of Science ®Google Scholar
• Cutolo M, Otsa K, Laas K, et al. Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: northern versus southern Europe. Clin Exp Rheumatol 2006;24:702–4
   PubMed Web of Science ®Google Scholar
• Patel S, Farragher T, Berry J, et al. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 2007;56:2143–9
   PubMed Web of Science ®Google Scholar
• Sadovnick AD. Genetic background of multiple sclerosis. Autoimmun Rev 2012;11:163–6
   PubMed Web of Science ®Google Scholar
• Sellner J, Kraus J, Awad A, et al. The increasing incidence and prevalence of female multiple sclerosis – a critical analysis of potential environmental factors. Autoimmun Rev 2011;10:495–502
   PubMed Web of Science ®Google Scholar
• Hanwell HEC, Banwell B. Assessment of evidence for a protective role of vitamin D in multiple sclerosis. Biochim Biophys Acta 2011;1812:202–12
   PubMed Web of Science ®Google Scholar
• Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol 2010;9:599–612
   PubMed Web of Science ®Google Scholar
• Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose vitamin D3 and mental well-being: randomised controlled trial. Br J Psychiatry 2011;198:357–64
   PubMed Web of Science ®Google Scholar
• Stein MS, Liu Y, Gray OM, et al. A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology 2011;77:1611–18
   PubMed Web of Science ®Google Scholar
• Burton JM, Kimball S, Vieth R, et al. A phase i/ii dose-escalation trial of vitamin D3 and calcium in multiple sclerosis (e–pub ahead of print) (LOE classification). Neurology 2010;74:1852–9
   PubMed Web of Science ®Google Scholar
• Smolders J, Peelen E, Thewissen M, et al. Safety and t cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis. PLoS ONE 2010;5:e15235
   PubMed Web of Science ®Google Scholar
• Muscogiuri G, Tirabassi G, Bizzaro G, et al. Vitamin D and thyroid disease: to D or not to D? Eur J Clin Nutr 2015;69:291–6
   PubMed Web of Science ®Google Scholar
• Tanpowpong P, Obuch JC, Jiang H, et al. Multicenter study on season of birth and celiac disease: evidence for a new theoretical model of pathogenesis. J Pediatr 2013;162:501–4
   PubMed Web of Science ®Google Scholar
• Dong JY, Zhang WG, Chen JJ, et al. Vitamin D intake and risk of type 1 diabetes: a meta-analysis of observational studies. Nutrients 2013;5:3551–62
   PubMed Web of Science ®Google Scholar
• Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 2010;39:365–79
   PubMed Web of Science ®Google Scholar
• Agmon-Levin N, Kopilov R, Selmi C, et al. Vitamin D in primary biliary cirrhosis, a plausible marker of advanced disease. Immunol Res 2015;61:141–6
   PubMed Web of Science ®Google Scholar
• Bailey EE, Ference EH, Alikhan A, et al. Combination treatments for psoriasis: a systematic review and meta-analysis. Arch Dermatol 2012;148:511–22
   PubMed Web of Science ®Google Scholar
• Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet 2014;2:76–89
   PubMed Web of Science ®Google Scholar
• Lips P, Netelenbos JC, Jongen MJ, et al. Histomorphometric profile and vitamin D status in patients with femoral neck fracture. Metab Bone Dis Relat Res 1982;4:85–93
   PubMedGoogle Scholar
• Lips P. Relative value of 25(OH)d and 1,25(OH)2d measurements. J Bone Miner Res 2007;22:1668–71
   PubMed Web of Science ®Google Scholar
• Need AG, O'Loughlin PD, Morris HA, et al. Vitamin D metabolites and calcium absorption in severe vitamin D deficiency. J Bone Miner Res 2008;23:1859–63
   PubMed Web of Science ®Google Scholar
• Farrell CJ, Martin S, McWhinney B, et al. State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin Chem 2012;58:531–42
   PubMed Web of Science ®Google Scholar
• Belsey R, Deluca HF, Potts JT Jr. Competitive binding assay for vitamin D and 25-OH vitamin D. J Clin Endocrinol Metab 1971;33:554–7
   PubMed Web of Science ®Google Scholar
• Haddad JG, Chyu KJ. Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab 1971;33:992–5
   PubMed Web of Science ®Google Scholar
• Eisman JA, Shepard RM, DeLuca HF. Determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma using high-pressure liquid chromatography. Anal Biochem 1977;80:298–305
   PubMed Web of Science ®Google Scholar
• Hollis BW, Napoli JL. Improved radioimmunoassay for vitamin D and its use in assessing vitamin D status. Clin Chem 1985;31:1815–19
   PubMed Web of Science ®Google Scholar
• Hollis BW, Kamerud JQ, Selvaag SR, et al. Determination of vitamin D status by radioimmunoassay with an 125i-labeled tracer. Clin Chem 1993;39:529–33
   PubMed Web of Science ®Google Scholar
• Bouillon R, Van Herck E, Jans I, et al. Two direct (nonchromatographic) assays for 25-hydroxyvitamin D. Clin Chem 1984;30:1731–6
   PubMed Web of Science ®Google Scholar
• Hollis BW. Comparison of commercially available (125)i-based ria methods for the determination of circulating 25-hydroxyvitamin D. Clin Chem 2000;46:1657–61
   PubMed Web of Science ®Google Scholar
• Glendenning P, Taranto M, Noble JM, et al. Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays. Ann Clin Biochem 2006;43:23–30
   PubMed Web of Science ®Google Scholar
• Roth HJ, Zahn I, Alkier R, Schmidt H. Validation of the first automated chemiluminescence protein-binding assay for the detection of 25-hydroxycalciferol. Clin Lab 2001;47:357–65
   PubMedGoogle Scholar
• Glendenning P, Noble JM, Taranto M, et al. Issues of methodology, standardization and metabolite recognition for 25-hydroxyvitamin D when comparing the diasorin radioimmunoassay and the nichols advantage automated chemiluminescence protein-binding assay in hip fracture cases. Ann Clin Biochem 3;40:546–51
   Google Scholar
• Leventis P, Garrison L, Sibley M, et al. Underestimation of serum 25-hydroxyvitamin D by the nichols advantage assay in patients receiving vitamin D replacement therapy. Clin Chem 2005;51:1072–4; author reply 4
   PubMed Web of Science ®Google Scholar
• Holmes EW, Garbincius J, McKenna KM. Non-linear analytical recovery in the diasorin liaison immunoassay for 25-hydroxy vitamin D. Clin Chim Acta 2011;412:2355–6
   PubMed Web of Science ®Google Scholar
• Cavalier E, Carlisi A, Bekaert AC, et al. Human anti-animal interference in diasorin liaison total 25(OH)-vitamin D assay: towards the end of a strange story? Clin Chim Acta 2012;413:527–8
   PubMed Web of Science ®Google Scholar
• Becker N, McClellan AC, Gronowski AM, Scott MG. Inaccurate 25-hydroxyvitamin D results from a common immunoassay. Clin Chem 2012;58:948–50
   PubMed Web of Science ®Google Scholar
• Leino A, Turpeinen U, Koskinen P. Automated measurement of 25-OH vitamin D3 on the roche modular e170 analyzer. Clin Chem 2008;54:2059–62
   PubMed Web of Science ®Google Scholar
• Connell AB, Jenkins N, Black M, et al. Overreporting of vitamin D deficiency with the roche elecsys vitamin D3 (25-OH) method. Pathology 2011;43:368–71
   PubMed Web of Science ®Google Scholar
• Chen Y, Kinney L, Bozovic A, et al. Performance evaluation of siemens advia centaur and roche modular analytics e170 total 25-OH vitamin D assays. Clin Biochem 2012;45:1485–90
   PubMed Web of Science ®Google Scholar
• Cavalier E, Lukas P, Crine Y, et al. Evaluation of automated immunoassays for 25(OH)-vitamin D determination in different critical populations before and after standardization of the assays. Clin Chim Acta 2014;431:60–5
   PubMed Web of Science ®Google Scholar
• Hermida FJ, Fernandez M, Laborda B, et al. Assessment of advia centaur analyzer for the measurement of 25-OH vitamin D. Clin Lab 2012;58:987–95
   PubMed Web of Science ®Google Scholar
• Hsu SA, Soldo J, Gupta M. Evaluation of two automated immunoassays for 25-OH vitamin D: comparison against LC-MS/MS. J Steroid Biochem Mol Biol 2013;136:139–45
   PubMed Web of Science ®Google Scholar
• Cavalier E, Carlisi A, Bekaert AC, et al. Analytical evaluation of the new Abbott Architect 25-OH vitamin D assay. Clin Biochem 2012;45:505–8
   PubMed Web of Science ®Google Scholar
• Cavalier E, Huberty V, Cormier C, Souberbielle JC. Overestimation of the 25(OH)d serum concentration with the automated IDS EIA kit. J Bone Miner Res 2011;26:434–6
   PubMed Web of Science ®Google Scholar
• Cluse ZN, Fudge AN, Whiting MJ, et al. Evaluation of 25-hydroxy vitamin D assay on the immunodiagnostic systems ISYS analyser. Ann Clin Biochem 2012;49:159–65
   PubMed Web of Science ®Google Scholar
• Heijboer AC, Blankenstein MA, Kema IP, Buijs MM. Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. Clin Chem 2012;58:543–8
   PubMed Web of Science ®Google Scholar
• Ajuria-Morentin I, Mar-Medina C, Bereciartua-Urbieta E, et al. Lack of transferability between different immunoassays and LC-MS/MS for total 25-hydroxyvitamin D measurement and disagreement defining deficiency. Scand J Clin Lab Invest 2013;73:82–6
   PubMed Web of Science ®Google Scholar
• Cater GD, Jones JC, Berry JL. The anomalous behaviour of exogenous 25-hydroxyvitamin D in competitive binding assays. J Steroid Biochem Mol Biol 2007;103:480–2
   PubMed Web of Science ®Google Scholar
• Shu I, Pina-Oviedo S, Quiroga-Garza G, et al. Influence of vitamin D2 percentage on accuracy of 4 commercial total 25-hydroxyvitamin D assays. Clin Chem 2013;59:1273–5
   PubMed Web of Science ®Google Scholar
• Gallo S, Comeau K, Agellon S, et al. Methodological issues in assessing plasma 25-hydroxyvitamin D concentration in newborn infants. Bone 2014;61:186–90
   PubMed Web of Science ®Google Scholar
• Singh RJ, Taylor RL, Reddy GS, Grebe SK. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab 2006;91:3055–61
   PubMed Web of Science ®Google Scholar
• Molnar F, Sigueiro R, Sato Y, et al. 1alpha,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor. PLoS ONE 2011;6:e18124
   PubMed Web of Science ®Google Scholar
• Kamao M, Tatematsu S, Hatakeyama S, et al. C-3 epimerization of vitamin D3 metabolites and further metabolism of c-3 epimers: 25-hydroxyvitamin D3 is metabolized to 3-epi-25-hydroxyvitamin D3 and subsequently metabolized through c-1alpha or c-24 hydroxylation. J Biol Chem 2004;279:15897–907
   PubMed Web of Science ®Google Scholar
• Morrison NA, Eisman JA. Nonhypercalcemic 1,25-(OH)2d3 analogs potently induce the human osteocalcin gene promoter stably transfected into rat osteosarcoma cells (rosco-2). J Bone Miner Res 1991;6:893–9
   PubMed Web of Science ®Google Scholar
• Norman AW, Bouillon R, Farach-Carson MC, et al. Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three a-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3. J Biol Chem 1993;268:20022–30
   PubMed Web of Science ®Google Scholar
• Brown AJ, Ritter C, Slatopolsky E, et al. 1alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion. J Cell Biochem 1999;73:106–13
   PubMed Web of Science ®Google Scholar
• Brown AJ, Ritter CS, Weiskopf AS, et al. Isolation and identification of 1alpha-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion. J Cell Biochem 2005;96:569–78
   PubMed Web of Science ®Google Scholar
• Shah I, Petroczi A, Naughton DP. Exploring the role of vitamin D in type 1 diabetes, rheumatoid arthritis, and Alzheimer disease: new insights from accurate analysis of 10 forms. J Clin Endocrinol Metab 2014;99:808–16
   PubMed Web of Science ®Google Scholar
• Schleicher RL, Encisco SE, Chaudhary-Webb M, et al. Isotope dilution ultra performance liquid chromatography-tandem mass spectrometry method for simultaneous measurement of 25-hydroxyvitamin D2, 25-hydroxyvitamin D3 and 3-epi-25-hydroxyvitamin D3 in human serum. Clin Chim Acta 2011;412:1594–9
   PubMed Web of Science ®Google Scholar
• Bruce SJ, Rochat B, Beguin A, et al. Analysis and quantification of vitamin D metabolites in serum by ultra-performance liquid chromatography coupled to tandem mass spectrometry and high-resolution mass spectrometry–a method comparison and validation. Rapid Commun Mass Spectrom 2013;27:200–6
   PubMed Web of Science ®Google Scholar
• Bailey D, Veljkovic K, Yazdanpanah M, Adeli K. Analytical measurement and clinical relevance of vitamin D(3) C3-epimer. Clin Biochem 2013;46:190–6
   PubMed Web of Science ®Google Scholar
• Shah I, James R, Barker J, et al. Misleading measures in vitamin D analysis: A novel LC-MS/MS assay to account for epimers and isobars. Nutr J 2011;10:46. doi: 10.1186/1475-2891-10-46
   PubMed Web of Science ®Google Scholar
• Stepman HC, Vanderroost A, Stockl D, Thienpont LM. Full-scan mass spectral evidence for 3-epi-25-hydroxyvitamin D(3) in serum of infants and adults. Clin Chem Lab Med 2011;49:253–6
   PubMed Web of Science ®Google Scholar
• van den Ouweland JM, Beijers AM, van Daal H. Fast separation of 25-hydroxyvitamin D3 from 3-epi-25-hydroxyvitamin D3 in human serum by liquid chromatography-tandem mass spectrometry: variable prevalence of 3-epi-25-hydroxyvitamin D3 in infants, children, and adults. Clin Chem 2011;57:1618–19
   PubMed Web of Science ®Google Scholar
• Lensmeyer G, Poquette M, Wiebe D, Binkley N. The c-3 epimer of 25-hydroxyvitamin D(3) is present in adult serum. J Clin Endocrinol Metab 2012;97:163–8
   PubMed Web of Science ®Google Scholar
• Yazdanpanah M, Bailey D, Walsh W, et al. Analytical measurement of serum 25-OH-vitamin D(3), 25-OH-vitamin D(2) and their C3-epimers by LC-MS/MS in infant and pediatric specimens. Clin Biochem 2013;46:1264–71
   PubMed Web of Science ®Google Scholar
• Goldman MM, Viec KV, Caulfield MP, et al. The measurement of 3-epimer 25-hydroxyvitamin D by mass spectrometry in clinical specimens detects inconsequential levels in adult subjects. J Investig Med 2014;62:690–5
   PubMed Web of Science ®Google Scholar
• Karras SN, Shah I, Petroczi A, et al. An observational study reveals that neonatal vitamin D is primarily determined by maternal contributions: implications of a new assay on the roles of vitamin D forms. Nutr J 2013;12:77. doi: 10.1186/1475-2891-12-77
   PubMed Web of Science ®Google Scholar
• Flynn N, Lam F, Dawnay A. Enhanced 3-epi-25-hydroxyvitamin D3 signal leads to overestimation of its concentration and amplifies interference in 25-hydroxyvitamin D LC-MS/MS assays. Ann Clin Biochem 2014;51:352–9
   PubMed Web of Science ®Google Scholar
• van den Ouweland JM, Beijers AM, van Daal H. Overestimation of 25-hydroxyvitamin D3 by increased ionisation efficiency of 3-epi-25-hydroxyvitamin D3 in LC-MS/MS methods not separating both metabolites as determined by an LC-MS/MS method for separate quantification of 25-hydroxyvitamin D3, 3-epi-25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human serum. J Chromatogr B Analyt Technol Biomed Life Sci 2014;967:195–202
   PubMed Web of Science ®Google Scholar
• Maunsell Z, Wright DJ, Rainbow SJ. Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins d2 and d3. Clin Chem 2005;51:1683–90
   PubMed Web of Science ®Google Scholar
• Cooke NE, Haddad JG. Vitamin D binding protein (gc-globulin). Endocr Rev 1989;10:294–307
   PubMed Web of Science ®Google Scholar
• Verboven C, Rabijns A, De Maeyer M, et al. A structural basis for the unique binding features of the human vitamin D-binding protein. Nat Struct Mol Biol 2002;9:131–6
   Web of Science ®Google Scholar
• Hattori N, Oda S, Sadahiro T, et al. Ykl-40 identified by proteomic analysis as a biomarker of sepsis. Shock 2009;32:393–400
   PubMed Web of Science ®Google Scholar
• Malik S, Fu L, Juras DJ, et al. Common variants of the vitamin D binding protein gene and adverse health outcomes. Crit Rev Clin Lab Sci 2013;50:1–22
   PubMed Web of Science ®Google Scholar
• Lauridsen AL, Vestergaard P, Hermann AP, et al. Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int 2005;77:15–22
   PubMed Web of Science ®Google Scholar
• Sinotte M, Diorio C, Berube S, et al. Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am J Clin Nutr 2009;89:634–40
   PubMed Web of Science ®Google Scholar
• Fu L, Yun F, Oczak M, et al. Common genetic variants of the vitamin D binding protein (dbp) predict differences in response of serum 25-hydroxyvitamin D [25(OH)d] to vitamin D supplementation. Clin Biochem 2009;42:1174–7
   PubMed Web of Science ®Google Scholar
• Jones KS, Assar S, Harnpanich D, et al. 25(OH)d2 half-life is shorter than 25(OH)d3 half-life and is influenced by dbp concentration and genotype. J Clin Endocrinol Metab 2014;99:3373–81
   PubMed Web of Science ®Google Scholar
• Bordier P, Rasmussen H, Marie P, et al. Vitamin D metabolites and bone mineralization in man. J Clin Endocrinol Metab 1978;46:284–94
   PubMed Web of Science ®Google Scholar
• Schlingmann KP, Kaufmann M, Weber S, et al. Mutations in cyp24a1 and idiopathic infantile hypercalcemia. N Engl J Med 2011;365:410–21
   PubMed Web of Science ®Google Scholar
• Dauber A, Nguyen TT, Sochett E, et al. Genetic defect in cyp24a1, the vitamin D 24-hydroxylase gene, in a patient with severe infantile hypercalcemia. J Clin Endocrinol Metab 2012;97:E268–74
   PubMed Web of Science ®Google Scholar
• Jacobs TP, Kaufman M, Jones G, et al. A lifetime of hypercalcemia and hypercalciurea, finally explained. J Clin Endocrinol Metab 2014;99:708–12
   PubMed Web of Science ®Google Scholar
• Kaufmann M, Gallagher JC, Peacock M, et al. Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD. J Clin Endocrinol Metab 2014;99:2567–74
   PubMed Web of Science ®Google Scholar
• Burild A, Frandsen HL, Jakobsen J. Simultaneous quantification of vitamin D(3), 25-hydroxyvitamin D(3) and 24,25-dihydroxyvitamin D(3) in human serum by LC-MS/MS. Scand J Clin Lab Invest 2014;74:418–23
   PubMed Web of Science ®Google Scholar
• Bosworth CR, Levin G, Robinson-Cohen C, et al. The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease. Kidney Int 2012;82:693–700
   PubMed Web of Science ®Google Scholar
• Briggs AD, Kuan V, Greiller CL, et al. Longitudinal study of vitamin D metabolites after long bone fracture. J Bone Miner Res 2013;28:1301–7
   PubMed Web of Science ®Google Scholar
• Vanderschueren D, Pye SR, O'Neill TW, et al. Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men: the European male aging study (EMAS). J Clin Endocrinol Metab 2013;98:995–1005
   PubMed Web of Science ®Google Scholar
• Lee DM, Vanderschueren D, Boonen S, et al. Association of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone with mortality among middle-aged and older European men. Age Ageing 2014;43:528–35
   PubMed Web of Science ®Google Scholar
• Kendrick J, Cheung AK, Kaufman JS, et al. Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease. Am J Kidney Dis 2012;60:567–75
   PubMed Web of Science ®Google Scholar
• Inaguma D, Nagaya H, Hara K, et al. Relationship between serum 1,25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease. Clin Exp Nephrol 2008;12:126–31
   PubMed Web of Science ®Google Scholar
• de Boer IH, Sachs MC, Cleary PA, et al. Circulating vitamin D metabolites and kidney disease in type 1 diabetes. J Clin Endocrinol Metab 2012;97:4780–8
   PubMed Web of Science ®Google Scholar
• Bouillon R, Van Baelen H. Transport of vitamin D: significance of free and total concentrations of the vitamin D metabolites. Calcif Tissue Int 1981;33:451–3
   PubMed Web of Science ®Google Scholar
• Safadi FF, Thornton P, Magiera H, et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest 1999;103:239–51
   PubMed Web of Science ®Google Scholar
• Bikle DD, Halloran BP, Gee E, et al. Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels. J Clin Invest 1986;78:748–52
   PubMed Web of Science ®Google Scholar
• Reese PP, Bloom RD, Feldman HI, et al. Changes in vitamin D binding protein and vitamin D concentrations associated with liver transplantation. Liver Int 2012;32:287–96
   PubMed Web of Science ®Google Scholar
• Al-oanzi ZH, Tuck SP, Raj N, et al. Assessment of vitamin D status in male osteoporosis. Clin Chem 2006;52:248–54
   PubMed Web of Science ®Google Scholar
• Powe CE, Ricciardi C, Berg AH, et al. Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res 2011;26:1609–16
   PubMed Web of Science ®Google Scholar
• Powe CE, Evans MK, Wenger J, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 2013;369:1991–2000
   PubMed Web of Science ®Google Scholar
• Glendenning P, Chew GT, Inderjeeth CA, et al. Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol. Bone 2013;56:271–5
   PubMed Web of Science ®Google Scholar
• Bell DA, Crooke MJ, Hay N, Glendenning P. Prolonged vitamin D intoxication: Presentation, pathogenesis and progress. Int Med J 2013;43:1148–50
   Google Scholar
• Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266–81
   PubMed Web of Science ®Google Scholar
• Vieth R. Why the optimal requirement for vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol 2004;89–90:575–9
   PubMed Web of Science ®Google Scholar
• Cranney A, Horsley T, O'Donnell S, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) 2007;(158):1–235
   PubMedGoogle Scholar
• Holick MF, Chen TC, Lu Z, Sauter E. Vitamin D and skin physiology: a d-lightful story. J Bone Miner Res 2007;22 Suppl 2:V28–33
   Google Scholar
• Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354:669–83
   PubMed Web of Science ®Google Scholar
• Sorensen MD, Kahn AJ, Reiner AP, et al. Impact of nutritional factors on incident kidney stone formation: a report from the WHI OS. J Urol 2012;187:1645–9
   PubMed Web of Science ®Google Scholar
• Bjelakovic G, Gluud LL, Nikolova D, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2014;1:CD007470
   Google Scholar
• Turner C, Dalton N, Inaoui R, et al. Effect of a 300 000-iu loading dose of ergocalciferol (vitamin D2) on circulating 1,25(OH)2-vitamin D and fibroblast growth factor-23 (fgf-23) in vitamin D insufficiency. J Clin Endocrinol Metab 2013;98:550–6
   PubMed Web of Science ®Google Scholar
• Rossini M, Adami S, Viapiana O, et al. Dose-dependent short-term effects of single high doses of oral vitamin D(3) on bone turnover markers. Calcif Tissue Int 2012;91:365–9
   PubMed Web of Science ®Google Scholar
• Rossini M, Gatti D, Viapiana O, et al. Short-term effects on bone turnover markers of a single high dose of oral vitamin D(3). J Clin Endocrinol Metab 2012;97:E622–6
   PubMed Web of Science ®Google Scholar
• Glendenning P, Chew GT. Controversies and consensus regarding vitamin D deficiency in 2015: whom to test and whom to treat? Med J Aust 2015;202:470–1
   PubMed Web of Science ®Google Scholar